General medical journalCurrentEndo coverage
New England Journal of Medicine
What CurrentEndo has captured from this journal. The coverage figures describe CurrentEndo's coverage, not the journal's output. Figures as of 14 November 2026.
CurrentEndo holds 55 Briefs from New England Journal of Medicine, most often randomized controlled trials and other research.
Follow all of it, or only:You follow this. See your week →Explore N Engl J Med with filters →
- Recent
- 3 Briefs
- past 90 days
- Archive
- 55 Briefs
- research published from January 2023 to today
- Editorial
- –
- no Weekly issue published yet
Topics
- T2D & otherin Explore1120.0%
- T1Din Explore35.5%
- Technologyin Explore23.6%
- Complicationsin Explore35.5%
- Diabetes in pregnancyin Explore23.6%
- Obesityin Explore2036.4%
- Pituitaryin Explore35.5%
- Adrenalin Explore35.5%
- Bone & mineralin Explore11.8%
- Reproductive endocrinein Explore35.5%
- Endocrine cancerin Explore23.6%
- Pediatricin Explore23.6%
Evidence types
- Randomized controlled trials4480.0%
- Secondary analyses23.6%
- Cohort studies11.8%
- Diagnostic & prognostic11.8%
- Mechanistic studies11.8%
- Other research610.9%
Shares are of the 55 Briefs CurrentEndo has covered from N Engl J Med, by primary topic and study type.
Publication activity
- 20267 Briefs
- 202516 Briefs
- 202416 Briefs
- 202316 Briefs
Latest from New England Journal of Medicine
N Engl J Med
Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity
Research articleObesity
N Engl J Med
Intensive Blood-Pressure Lowering in Patients with Type 2 Diabetes
Randomized controlled trialT2D & other
N Engl J Med
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
Randomized controlled trialObesity
N Engl J Med
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity
Randomized controlled trialObesity
N Engl J Med
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia
Randomized controlled trialPediatric
N Engl J Med
Survodutide Once Weekly for the Treatment of Adults with Obesity
Randomized controlled trialObesity
N Engl J Med
Finerenone in Type 1 Diabetes and Chronic Kidney Disease
Randomized controlled trialComplications
N Engl J Med
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
Randomized controlled trialComplications
N Engl J Med
Belzutifan for Advanced Pheochromocytoma or Paraganglioma
Research articleAdrenal
N Engl J Med
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
Randomized controlled trialObesity
N Engl J Med
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
Randomized controlled trialObesity
N Engl J Med
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
Randomized controlled trialObesity
N Engl J Med
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
Randomized controlled trialT2D & other
N Engl J Med
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
Randomized controlled trialT2D & other
N Engl J Med
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
Randomized controlled trialObesity
N Engl J Med
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
Randomized controlled trialT2D & other
N Engl J Med
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
Research articleT1D
N Engl J Med
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
Randomized controlled trialT2D & other
N Engl J Med
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
Randomized controlled trialObesity
N Engl J Med
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Randomized controlled trialObesity
N Engl J Med
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Randomized controlled trialT2D & other
N Engl J Med
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
Randomized controlled trialTechnology
N Engl J Med
Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age
Randomized controlled trialBone & mineral
N Engl J Med
Oral Infigratinib Therapy in Children with Achondroplasia
Research articlePediatric
N Engl J Med
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Randomized controlled trialObesity
N Engl J Med
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
Randomized controlled trialT2D & other
N Engl J Med
Tirzepatide for Obesity Treatment and Diabetes Prevention
Secondary analysisObesity
N Engl J Med
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
Randomized controlled trialObesity
N Engl J Med
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
Randomized controlled trialEndocrine cancer
N Engl J Med
Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial
Randomized controlled trialObesity
N Engl J Med
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
Randomized controlled trialT2D & other
N Engl J Med
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Randomized controlled trialObesity
N Engl J Med
Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia
Randomized controlled trialAdrenal
N Engl J Med
Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
Randomized controlled trialAdrenal
N Engl J Med
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
Mechanistic studyPituitary
N Engl J Med
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Randomized controlled trialComplications
N Engl J Med
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Randomized controlled trialT2D & other
N Engl J Med
Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease
Randomized controlled trialT2D & other
N Engl J Med
Testosterone Treatment and Fractures in Men with Hypogonadism
Secondary analysisReproductive endocrine
N Engl J Med
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
Randomized controlled trialT1D